A rationale for fluorescent dyes is the highly specific visualization of cellular components with the help of fluorescent agents. It can be a fluorescent protein,
Immune cells in a broad sense refer to all cells involved in or related to immune responses, mainly all leukocytes and non-leukocyte antigen-presenting cells (such
Fluorescein is divided into four categories according to the excitation wavelength, which are mainly 375nm, 405nm, 488nm and 633nm. Among them, fluoresceins with excitation wavelengths
Monoclonal antibody drugs, the full name is also known as monoclonal antibody drugs. As the name suggests, these drugs are closely related to the body’s
Basel, 6 July 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s
YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer ScienceDirect Cancer immunotherapy is a breakthrough for
On July 5, AstraZeneca announced that it intends to acquire biotech company TeneoTwo and will receive a bispecific molecular therapy in Phase 1 clinical trials.
RED BANK, N.J., June 30, 2022 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB) (the “Company”), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases,
As a new type of immunotherapy, CAR-T cell therapy boosts a patient’s killer T cells to attack and eliminate cancer. It can be as high
1. Trodelvy Trodelvy (sacituzumab govitecan-hziy) is the first approved antibody-conjugated drug targeting Trop-2 (human trophoblast cell surface antigen 2), and has been granted breakthrough therapy
1. Conjugation of Lysine ResiduesThis method attaches the payload to the lysine residue of the antibody through a linker containing an active carboxylate site. 2.
Although the research history is short and there are few types of ADC drugs on the market, these drugs play an important role in the
